Australia still prone to “radical” shortages post-pandemic

GBMA’s Jane Halton says pandemic lesson is pricing, lack of market influence and geography still leave Australia’s medicines supply vulnerable A senior pharma industry leader has warned Australia is still vulnerable to serious stock shortages and needs to remember the health security lessons learnt from the pandemic. Speaking at the APP2023’s State Of The Industry